Past Podcast Episodes

This past weekend, 8,000 MS research scientists and clinicians gathered virtually for the joint meeting of the Americas Committee for Treatment and Research in Multiple Sclerosis and the European Committee for Treatment and Research in Multiple Sclerosis. Known as ACTRIMS-ECTRIMS, this year's conference was appropriately re-branded as MSVirtual2020.

We're talking about great presentations on the MS prodrome (and we'll explain what that is and why it's important), when it might be time to discontinue MS disease-modifying therapies, some encouraging progressive MS clinical trial results, the new number for global MS prevalence, and more!

We have a lot to talk about. Welcome to MSVirtual2020!

The MS Prodrome :56

When is it appropriate to discontinue disease-modifying therapy in MS? 4:18

Study shows Masitinib slows disability progression in progressive MS 6:49

Multiple Sclerosis International Federation announces the Atlas of MS, with Clare Walton 9:08

Study shows disease-modifying therapy may delay disability progression and time until people with primary progressive MS need a wheelchair 20:55

Study analyzes benefits of Wahls Diet & Swank Diet 22:47

Atara Biotherapeutics shares initial data from its ATA-188 cell therapy clinical trial, with Dr. AJ Joshi 24:07

Share this episode 40:17

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/MSVirtual2020

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Bonus Episode:
Guests: Clare Walton, Dr. AJ Joshi

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, MSVirtual2020, RealTalkMS

Privacy Policy

You can't control the weather, but you can learn to dance in the rain. And developing resilience teaches you how to dance in the rain. My guest is Dr. Dawn Ehde, a clinical psychologist and professor of rehabilitation medicine at University of Washington Medicine. Dr. Ehde is an expert in understanding resilience, and she's joining us to explain why having resilience is central to improving the well-being of people affected by MS, and how to go about building your resilience — even in the midst of a global pandemic.

We're also talking about Bafiertam, a lower-cost, FDA-approved bioequivalent to Tecfidera.

We'll share the results of a study of more than 5,000 people who were newly diagnosed with MS — and not prescribed a disease-modifying therapy for two years following their diagnosis. We'll also explain why that's just wrong!

We'll talk to Suzi Claflin, the academic lead for Understanding Multiple Sclerosis, a free comprehensive 6-week online course that's open for registration right now.

And we'll remind you about where you can register for next week's Black MS Experience Summit.

We have a lot to talk about! Are you ready for RealTalk MS??!

We're celebrating 3 amazing years! :22

The joint ACTRIMS-ECTRIMS meeting took place last weekend and that means a bonus episode of RealTalk MS is coming 2:38

Bafiertam is now available in the United States 4:44

Study shows that 2/3 of people newly diagnosed with MS in the U.S. are not prescribed any disease-modifying therapy for 2 years following their diagnosis 5:43

Understanding Multiple Sclerosis, a free online course, is open for registration. My interview with Suzi Claflin 8:44

The Black MS Experience Summit takes place next week 21:51

My Interview with Dr. Dawn Ehde 23:43

Share this episode 40:32

Donate to the National MS Society COVID-19 Response Fund 40:52

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/159

ADD YOUR VOICE TO THE CONVERSATION

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society's Ask An MS Expert Video Replay

What You Need to Know About Coronavirus (COVID-19)

Bafiertam

STUDY: Treatment Patterns and Comorbid Burden of Patients Newly Diagnosed with Multiple Sclerosis in the United States

“Understanding Multiple Sclerosis” Online Course Registration

National MS Society Black MS Experience Summit

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review